The global psoriasis drugs market is estimated to value USD 21.4 billion by 2022, according the findings of a report published by Grand View Research, Inc. Rising cases of psoriasis due to genetic or environmental factors is expected to stimulate the demand for advanced drugs and therapies. Such treatments help decelerate the harshness of the disease by pausing keratinocyte hyper proliferation. This, in turn, is expected to boost the global market development over the forecast period (from 2016 to 2022).
Unavailability of appropriate therapeutics or drugs for the disease treatment is anticipated to further propel the psoriasis therapeutics demand in the coming years. Considering the escalating demand, a lot of major drug companies are focusing on the R&D to offer advanced level of therapeutics for the psoriasis treatment. For instance, Ortho Dermatologics recently announced the acceptance of their application for new drug JEMDEL by U.S. Food and Drug Administration (FDA). According to the developer, the new drug is the first ever high-potency steroid to treat plaque psoriasis in around eight weeks.
For More Insight Click Here : https://www.grandviewresearch.com/industry-analysis/psoriasis-drugs-market
In another instance, Clarify Medical recently announced that United States Patent and Trademark Office issued them patent, Phototherapy Light Engine. This patent covers precision, targeted phototherapy device, reflectors, thermal management system, and window filter. It can optimize uniformity and therapeutic power of narrowband UVB light treatment.
The global psoriasis drugs market is estimated to expand at a healthy growth rate of 9.3 % from 2016 to 2022. Growing awareness regarding the disease is anticipated to propel growth of the global market in the coming years. Moreover, availability of advanced diagnostic techniques due to technological innovations would also spur market development. Rising number of reimbursement policies for treatment is expected to further impel the market expansion. In addition, unavailability of the exact causes and treatments for the disease are also likely to augment the market demand during the next few years. Some of the leading companies offering effective therapeutics for psoriasis are Novartis AG; Eli Lilly & Company; AbbVie Inc.; Amgen Inc.; Johnson & Johnson; and AstraZeneca.
For More Insight Click Here : https://www.grandviewresearch.com/industry-analysis/psoriasis-drugs-market/request
Unavailability of appropriate therapeutics or drugs for the disease treatment is anticipated to further propel the psoriasis therapeutics demand in the coming years. Considering the escalating demand, a lot of major drug companies are focusing on the R&D to offer advanced level of therapeutics for the psoriasis treatment. For instance, Ortho Dermatologics recently announced the acceptance of their application for new drug JEMDEL by U.S. Food and Drug Administration (FDA). According to the developer, the new drug is the first ever high-potency steroid to treat plaque psoriasis in around eight weeks.
For More Insight Click Here : https://www.grandviewresearch.com/industry-analysis/psoriasis-drugs-market
In another instance, Clarify Medical recently announced that United States Patent and Trademark Office issued them patent, Phototherapy Light Engine. This patent covers precision, targeted phototherapy device, reflectors, thermal management system, and window filter. It can optimize uniformity and therapeutic power of narrowband UVB light treatment.
The global psoriasis drugs market is estimated to expand at a healthy growth rate of 9.3 % from 2016 to 2022. Growing awareness regarding the disease is anticipated to propel growth of the global market in the coming years. Moreover, availability of advanced diagnostic techniques due to technological innovations would also spur market development. Rising number of reimbursement policies for treatment is expected to further impel the market expansion. In addition, unavailability of the exact causes and treatments for the disease are also likely to augment the market demand during the next few years. Some of the leading companies offering effective therapeutics for psoriasis are Novartis AG; Eli Lilly & Company; AbbVie Inc.; Amgen Inc.; Johnson & Johnson; and AstraZeneca.
For More Insight Click Here : https://www.grandviewresearch.com/industry-analysis/psoriasis-drugs-market/request
ConversionConversion EmoticonEmoticon